In addition, neuroblastoma-bearing MYCN transgenic zebrafish at 0.5–1.5 years of age overexpressing dβh:EGFP-MYCN [21], were treated with 2 μl of vehicle (100% DMSO), 1 μl of SAHA (21 mg/kg), 1 μl of SE486-11 (30 mg/kg), or 1 μl of SAHA plus 1 μl of SE486-11 by oral gavage [22]. Here, MYCN is linked to neuroblastoma.